Title: HMne-Hospital Medicine – Neurology: Headaches; Stroke; Syncope/Vertigo
Faculty:Gerald W. Smetana, M.D., M.A.C.P,. Kendal Williams, M.D., M.P.H.
Original Release Date: July 1, 2020 Expiration Date: July 1, 2023
TOPIC 1 Treatment of Primary Headache Syndromes.
Upon completion of this session, the participant should be able to: EBM, GL, COMP
- Appreciate the role of abortive therapy for migraine, tension-type, and cluster headaches.
- Recognize the range of options for pharmacologic acute and preventive therapy, as recommended by the AHS 2015 Evidence-Based recommendations for migraine, as well as options for tension-type, and cluster headaches.
- Develop non-pharmacologic treatment strategies for migraine as per the most recent Cochrane Systematic Review.
TOPIC 2 Update on the Management of Stroke and Transient Ischemic Attack.
Upon completion of this session, the participant should be able to: GL, COMP
- Assess common presentations of cerebrovascular insufficiency.
- Prescribe the initial management of patients with a suspected acute CVA.
- Apply cutting edge strategies and therapies for the management of hemorrhagic and thrombotic strokes.
- Distinguish between stroke and TIA and appropriately assess the patient with TIA for early risk of stroke.
- Formulate an effective post-stroke secondary prevention plan as per the AHA/ASA guidelines.
TOPIC 3: The Evaluation and Management of Syncope and Vertigo.
Upon completion of this session, the participant should be able to: GL, COMP
- Appropriately evaluate patients with syncope or vertigo.
- Formulate a diagnostic evaluation strategy of syncope or vertigo that is based on best practices and the 2017 ACC/AHA/HRS guidelines.
- Debate the value of the various diagnostic approaches to the workup of syncope.
- Prescribe an effective therapeutic strategy for the management of both syncope and vertigo per the 2017 ACC/AHA/HRS guidelines.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.